Richard Frothingham. Show Affiliations »
Abstract
Mesh： See more » Cost SavingsCost-Benefit AnalysisDrug CostsFluoroquinolones/adverse effectsFluoroquinolones/economicsGatifloxacinHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHydroxymethylglutaryl-CoA Reductase Inhibitors/economicsQuinolines/adverse effectsQuinolines/economics
Substances： See more » FluoroquinolonesHydroxymethylglutaryl-CoA Reductase InhibitorsQuinolinesGatifloxacin
Year: 2004 PMID： 15141054 DOI： 10.1056/NEJM200405133502019
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245